{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:17:56Z","timestamp":1788254276936,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40618-015-0346-z","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T05:13:09Z","timestamp":1438146789000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The impact of oral contraceptives on cardiometabolic parameters"],"prefix":"10.1007","volume":"39","author":[{"given":"M.","family":"Farahmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rostami Dovom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"346_CR1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/dml028","volume":"12","author":"ESHRE","year":"2006","unstructured":"ESHRE (2006) Hormones and cardiovascular health in women. Hum Reprod Update 12:483\u2013497","journal-title":"Hum Reprod Update"},{"issue":"5728","key":"346_CR2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","volume":"308","author":"ME Mendelsohn","year":"2005","unstructured":"Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308(5728):1583\u20131587","journal-title":"Science"},{"key":"346_CR3","first-page":"89","volume":"877","author":"WHO","year":"1998","unstructured":"WHO (1998) Cardiovascular disease and steroid hormone contraception. Tech Rep Ser 877:89","journal-title":"Tech Rep Ser"},{"issue":"3","key":"346_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(95)00153-2","volume":"52","author":"IF Godsland","year":"1995","unstructured":"Godsland IF, Crook D, Devenport M, Wynn V (1995) Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception 52(3):143\u2013149","journal-title":"Contraception"},{"issue":"23","key":"346_CR5","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.1977.03270500051024","volume":"237","author":"IR Fisch","year":"1977","unstructured":"Fisch IR, Frank J (1977) Oral contraceptives and blood pressure. JAMA 237(23):2499\u20132503","journal-title":"JAMA"},{"issue":"4","key":"346_CR6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/jcem-33-4-671","volume":"33","author":"MD Cain","year":"1971","unstructured":"Cain MD, Walters WA, Catt KJ (1971) Effects of oral contraceptive therapy on the renin-angiotensin system. J Clin Endocrinol Metab 33(4):671\u2013676","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"346_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01849516","volume":"4","author":"M Blum","year":"1988","unstructured":"Blum M, Zacharovich D, Gelernter I, Blum I (1988) Influence of oral contraceptive treatment on blood pressure and 24-hour urinary catecholamine excretion in smoking as compared with non-smoking women. Adv Contracept 4(2):143\u2013149","journal-title":"Adv Contracept"},{"issue":"7","key":"346_CR8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-9378(72)90811-3","volume":"112","author":"WN Spellacy","year":"1972","unstructured":"Spellacy WN, Birk SA (1972) The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure. Am J Obstet Gynecol 112(7):912\u2013919","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"346_CR9","first-page":"905","volume":"14","author":"JA Whitworth","year":"1992","unstructured":"Whitworth JA, Scoggins BA, Andrews J, Williamson PM, Brown MA (1992) Haemodynamic and metabolic effects of short term administration of synthetic sex steroids in humans. Clin Exp Hypertens A 14(5):905\u2013922","journal-title":"Clin Exp Hypertens A"},{"issue":"20","key":"346_CR10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","volume":"323","author":"IF Godsland","year":"1990","unstructured":"Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B et al (1990) The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 323(20):1375\u20131381","journal-title":"N Engl J Med"},{"issue":"2","key":"346_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1559-4572.2008.00038.x","volume":"4","author":"JR Klaus","year":"2009","unstructured":"Klaus JR, Hurwitz BE, Llabre MM, Skyler JS, Goldberg RB, Marks JB et al (2009) Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function. J Cardiometab Syndr 4(2):63\u201371","journal-title":"J Cardiometab Syndr"},{"issue":"Suppl B","key":"346_CR12","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S1550-8579(07)80056-8","volume":"4","author":"V Regitz-Zagrosek","year":"2007","unstructured":"Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4(Suppl B):S162\u2013S177","journal-title":"Gend Med"},{"issue":"7","key":"346_CR13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/09513590902770149","volume":"25","author":"BE Hurwitz","year":"2009","unstructured":"Hurwitz BE, Henry N, Goldberg RB (2009) Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999\u20132004. Gynecol Endocrinol 25(7):441\u2013449","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"346_CR14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.ATV.16.3.431","volume":"16","author":"EA Brinton","year":"1996","unstructured":"Brinton EA (1996) Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 16(3):431\u2013440","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"346_CR15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s000380200008","volume":"47","author":"F Azizi","year":"2002","unstructured":"Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M et al (2002) Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 47(6):408\u2013426","journal-title":"Soz Praventivmed"},{"key":"346_CR16","unstructured":"http:\/\/www.who.int\/mediacentre\/factsheets\/fs355\/en\/ . Accessed Jan 2015"},{"issue":"16","key":"346_CR17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640\u20131645","journal-title":"Circulation"},{"issue":"3","key":"346_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","volume":"287","author":"ES Ford","year":"2002","unstructured":"Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356\u2013359","journal-title":"JAMA"},{"issue":"11","key":"346_CR19","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28(11):2745\u20132749","journal-title":"Diabetes Care"},{"issue":"5","key":"346_CR20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","volume":"85","author":"CN Merz","year":"2006","unstructured":"Merz CN, Johnson BD, Berga S, Braunstein G, Reis SE, Bittner V (2006) Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation. Fertil Steril 85(5):1425\u20131431","journal-title":"Fertil Steril"},{"issue":"6","key":"346_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-7824(01)00208-6","volume":"63","author":"P Coney","year":"2001","unstructured":"Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD (2001) Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 63(6):297\u2013302","journal-title":"Contraception"},{"issue":"11","key":"346_CR22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/09513590701582539","volume":"23","author":"S Lello","year":"2007","unstructured":"Lello S, Vittori G, Paoletti AM, Sorge R, Guardianelli F, Melis GB (2007) Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 microg plus levonorgestrel 100 microg. Gynecol Endocrinol 23(11):632\u2013637","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"346_CR23","first-page":"1277","volume":"79","author":"RM Watanabe","year":"1994","unstructured":"Watanabe RM, Azen CG, Roy S, Perlman JA, Bergman RN (1994) Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. J Clin Endocrinol Metab 79(5):1277\u20131283","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"346_CR24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.280.6.533","volume":"280","author":"SL Kjos","year":"1998","unstructured":"Kjos SL, Peters RK, Xiang A, Thomas D, Schaefer U, Buchanan TA (1998) Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 280(6):533\u2013538","journal-title":"JAMA"},{"issue":"2","key":"346_CR25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.contraception.2004.08.002","volume":"71","author":"CA Guazzelli","year":"2005","unstructured":"Guazzelli CA, Lindsey PC, de Araujo FF, Barbieri M, Petta CA, Aldrighi JM (2005) Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives. Contraception 71(2):118\u2013121","journal-title":"Contraception"},{"issue":"3","key":"346_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","volume":"65","author":"I Wiegratz","year":"2002","unstructured":"Wiegratz I, Lee JH, Kutschera E, Bauer HH, von Hayn C, Moore C et al (2002) Effect of dienogest-containing oral contraceptives on lipid metabolism. Contraception 65(3):223\u2013229","journal-title":"Contraception"},{"issue":"5","key":"346_CR27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0026-0495(99)90068-9","volume":"48","author":"MC Cheung","year":"1999","unstructured":"Cheung MC, Walden CE, Knopp RH (1999) Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles. Metabolism 48(5):658\u2013664","journal-title":"Metabolism"},{"issue":"5","key":"346_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2796.2001.00906.x","volume":"250","author":"JM Kemmeren","year":"2001","unstructured":"Kemmeren JM, Algra A, Grobbee DE (2001) Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation. J Intern Med 250(5):441\u2013448","journal-title":"J Intern Med"},{"issue":"17","key":"346_CR29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","volume":"325","author":"BW Walsh","year":"1991","unstructured":"Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325(17):1196\u20131204","journal-title":"N Engl J Med"},{"issue":"9","key":"346_CR30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0026-0495(93)90273-Q","volume":"42","author":"H Campos","year":"1993","unstructured":"Campos H, Sacks FM, Walsh BW, Schiff I, O\u2019Hanesian MA, Krauss RM (1993) Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 42(9):1153\u20131158","journal-title":"Metabolism"},{"issue":"5","key":"346_CR31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/meta.2002.31991","volume":"51","author":"A Ritsch","year":"2002","unstructured":"Ritsch A, Kaser S, Volgger B, Abfalter E, Sturm W, Ganzer H et al (2002) Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy. Metabolism 51(5):599\u2013604","journal-title":"Metabolism"},{"issue":"4","key":"346_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2003.10.013","volume":"47","author":"IF Godsland","year":"2004","unstructured":"Godsland IF (2004) Biology: risk factor modification by OCs and HRT lipids and lipoproteins. Maturitas 47(4):299\u2013303","journal-title":"Maturitas"},{"issue":"2","key":"346_CR33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1210\/jcem-57-2-262","volume":"57","author":"EJ Schaefer","year":"1983","unstructured":"Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI (1983) The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 57(2):262\u2013267","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"346_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2275(20)30144-9","volume":"43","author":"DR Jones","year":"2002","unstructured":"Jones DR, Schmidt RJ, Pickard RT, Foxworthy PS, Eacho PI (2002) Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 43(3):383\u2013391","journal-title":"J Lipid Res"},{"issue":"3 Suppl","key":"346_CR35","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1016\/S0010-7824(98)00079-1","volume":"58","author":"BR Carr","year":"1998","unstructured":"Carr BR (1998) Uniqueness of oral contraceptive progestins. Contraception 58(3 Suppl):23S\u201327S quiz 67S","journal-title":"Contraception"},{"issue":"4","key":"346_CR36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2003.11.003","volume":"69","author":"U Gaspard","year":"2004","unstructured":"Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R (2004) A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception 69(4):271\u2013278","journal-title":"Contraception"},{"key":"346_CR37","unstructured":"Tehrani FR (2006) Contraception use behavior of Iranian women (5 selected provinces of Iran), Iran. Report No.: final research project report"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0346-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0346-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T11:00:15Z","timestamp":1652958015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0346-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}